Platform
Company
Metabolic Disorders
Review status
Currently under review
Pending specialist review and validation.
Total acylcarnitine measures the amount of carnitine that is carrying fatty acids in your blood. Carnitine helps move fatty acids into mitochondria, where your body turns them into energy. When a fatty acid is attached to carnitine it is called an acylcarnitine; the sum of these is the total acylcarnitine.
This test reflects how your body is handling fat metabolism and the balance between free carnitine and its esterified forms. It is typically performed on a blood sample using mass spectrometry and is often interpreted alongside free carnitine and a detailed acylcarnitine profile.
Clinicians use this test when there is concern for disorders of fatty acid oxidation or carnitine transport, after an abnormal newborn screen, or when symptoms suggest impaired energy metabolism such as low blood sugar, muscle weakness, cardiomyopathy, or liver dysfunction. It can also be useful during critical illness, when the body’s energy use shifts under stress.
Results can help guide diagnosis, treatment decisions such as carnitine supplementation, and monitoring over time. Changes can also reflect kidney or liver function and the effects of certain medications. Interpreting total acylcarnitine together with other tests helps identify whether an inherited condition, nutrition, illness, or drugs are influencing your metabolism.
Your result is interpreted together with free carnitine, the ratio of acyl to free carnitine, and patterns from a comprehensive acylcarnitine profile. Higher values can be seen when acyl groups accumulate or clearance is reduced, which may occur with inherited fatty acid oxidation defects, significant metabolic stress, or kidney problems. Lower values may reflect limited carnitine availability, reduced intake, or specific transport defects.
One number rarely tells the whole story. Your clinician will consider your symptoms, diet, fasting status, medications, and other labs. Follow‑up may include a full acylcarnitine profile, urine organic acids, plasma amino acids, or genetic testing. If you take carnitine, the timing and dose relative to your blood draw can affect interpretation, so be sure to share these details.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Prolonged fasting, fever, or acute illness can shift metabolism toward fat use and increase acylcarnitines, potentially affecting interpretation.
Valproate, pivalate‑containing antibiotics, certain antiepileptics, and some antiretrovirals can alter carnitine metabolism. Carnitine supplements raise measured values.
Reduced kidney clearance or liver dysfunction can change acylcarnitine concentrations and patterns independent of genetic disorders.
Hemolysis, delayed processing, or improper storage can degrade or alter analytes, leading to misleading results.
Newborns, infants, and pregnant individuals may have different metabolic states, influencing acylcarnitine levels and requiring context‑specific interpretation.
High‑fat diets, recent heavy exercise, or use of medium‑chain triglycerides can shift acylcarnitine patterns without an underlying genetic disorder.
References